Added to YB: 2024-05-14
Pitch date: 2024-05-13
ENZ [bullish]
Enzo Biochem, Inc.
-31.6%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$35.7M
Pitch Price
$1.02
Price Target
2.40 (+243%)
Dividend
14.68%
EV/EBITDA
-0.21
P/E
-4.53
EV/Sales
0.07
Sector
Life Sciences Tools and Services
Category
special_situation
Enzo Biochem, Inc. - $ENZ
ENZ: Now at $1.05 with 18-130% upside. Recently sold Clinical Labs, but tax drag & ransomware attack left co with cash-burning remainco. Upside now from 1) Trades near NCAV, zero value for Life Sci biz (ELS) & real estate 2) ELS now profitable ($35M rev run-rate, 14% YoY growth, expanding margins) 3) Activists pushing to unlock value, new CEO incentivized for sale. ELS worth $0.65-1.30 (2-4x GP) + $1.01 NCAV/share + $0.20-0.28 real estate. Risks: Ransomware litigation (likely $3-6M, insured for $3M), delayed strategic action, ELS regression. Downside protected by discount to NCAV.
Read full article (11 min)